Biostate AI, Inc

Operating

Software & AI · Palo Alto, CA

Biostate AI develops AI-powered biotech technology for medical prognosis and diagnosis, building models that predict clinical outcomes. The filing reports early-stage results across multiple cohorts of over 75% on three key clinical prediction targets, with a prospective clinical study still needed.

Latest valuation

—

No round has disclosed a priced valuation or cap.

Total raised

$16,394,852

Crowd $659K · Private $15.7M · 8 rounds since 2023

Financials

FY2022–FY2025 · from SEC filings · hover any figure for its source

2022

−$900K

2023

$67K

−$5.4M

2024

$565K

−$9.9M

2025

RevenueNet income — beside revenue when positive, below the line when a loss

Metric

FY2022 unaudited

FY2023 unaudited

FY2024 reviewed

FY2025 reviewed

Income statement

Revenue

$66,700

$565,452

Cost of goods sold

$104,466

$690,981

Gross margin

—

-57%

-22%

Net income

-$900,389

-$5,407,609

-$9,881,728

Taxes paid

Balance sheet

Cash

$523,699

$1,694,986

$2,348,306

Accounts receivable

$7,040

$147,764

Total assets

$549,400

$3,420,773

$4,485,898

Short-term debt

$226,026

$913,728

$2,501,635

Long-term debt

$1,190,000

$8,616,179

$1,065,588

Total liabilities

$1,416,026

$9,529,907

$3,567,223

Other

Headcount

—

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Cap table

Principal holders% as the filing states it, Jul 14, 2026

David Y Zhang20%+of votes

Sold to the crowd

Reg CF · Apr 2026$659K· 481 investors

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Reg CF · SAFE · Apr 2026Closedvia WeFunder

Raised $659K / $618KInvestors 481

Section 4(a)(2) · SAFE · Dec 2025Closed

Raised $500K

Section 4(a)(2) · SAFE · Nov 2024Closed

Raised $5.7M

Reg CF · SAFE · Jan 2025Closedvia WeFunder

Raised $0 / $1.2M

Rule 506(b) · Equity · Apr 2025Closed

Raised $4.2MInvestors 7

Private · SAFE · Jun 2024Closed

Raised $3.3M

Rule 506(b) · Equity · Aug 2023Closed

Raised $1MInvestors 1

Section 4(a)(2) · SAFE · Aug 2023Closed

Raised $1.1M

Team

3 people

Ashwin GopinathFounder

Co-Founder

Dave ZhangFounder

Co-Founder/CEO

Jeremy Sobotta

CFO

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Delinquent

Filed 1 of 2 annual reports (FY2024–FY2025)

Missing: 2024

481 investors

holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

Form C/AJul 14, 20260001990762-26-000006
EDGAR
Form C-ARApr 17, 20260001990762-26-000004
EDGAR
Form CApr 17, 20260001990762-26-000005
EDGAR
Form DMay 12, 20250001990762-25-000001
EDGAR
Form CJan 31, 20250001670254-25-000038
EDGAR
Form DAug 23, 20230001990762-23-000001
EDGAR

Source: SEC EDGARCIK 0001990762DELast synced Aug 17, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.